AIM
RGLS

Ada Investment Management’s Regulus Therapeutics RGLS Stock Holding History

Ada Investment Management’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$96K Buy
+91
New +$91.2K 0.06% 368

Other funds holding RGLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ada Investment Management's RGLS Position: Q4 2015 in Review

Ada Investment Management opened a new position in Regulus Therapeutics (RGLS) in Q4 2015: 91 shares worth $96K. The stake represents 0.06% of the portfolio and ranks #368 among its holdings.

103 funds tracked by Wall St. Rank hold RGLS as of Q4 2015.

  • Ada Investment Management held 91 shares of Regulus Therapeutics worth $96K as of Q4 2015.
  • Regulus Therapeutics was a new Ada Investment Management position in Q4 2015.
  • Regulus Therapeutics made up 0.06% of Ada Investment Management's portfolio in Q4 2015, its #368 holding.
  • 103 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q4 2015.

Based on Ada Investment Management's 13F filing for Q4 2015, filed 19 Feb 2016.